Dynavax Selects Clinical Candidate For Flu Vaccine Program
Dynavax also said that the trial will be conducted at centers that are members of the Vaccine Testing and Evaluation Units (VTEUs) of the National Institute for Allergy
Life sciences and technology companies supported by the Ontario Bioscience Innovation Organization’s (OBIO) Capital Access Advisory Program (CAAP) have collectively raised more than C$1bn ($704.7m) in capital.
Meditel uses Global Cardio 3-Lead to record patient electrocardiograms (ECGs), create ECG reports and distribute those reports to the patient’s physician. Federico Vago, technical and operational manager at